美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）
检索条件:" 注册申请号=BLA761170"
符合检索条件的记录共 4 条，共 1 页，当前第 1 页 ，可点击列名称排序
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
50242-245-01 50242-245 HUMAN PRESCRIPTION DRUG Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf INJECTION, SOLUTION SUBCUTANEOUS 20200629 N/A BLA BLA761170 Genentech, Inc. HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB 30000 U/15mL; 1200 mg/15mL; 600 mg/15mL 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-01) / 15 mL in 1 VIAL, SINGLE-DOSE
50242-245-86 50242-245 HUMAN PRESCRIPTION DRUG Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf INJECTION, SOLUTION SUBCUTANEOUS 20210503 N/A BLA BLA761170 Genentech, Inc. HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB 30000 U/15mL; 1200 mg/15mL; 600 mg/15mL 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-245-86) / 15 mL in 1 VIAL, SINGLE-DOSE
50242-260-01 50242-260 HUMAN PRESCRIPTION DRUG Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf INJECTION, SOLUTION SUBCUTANEOUS 20200629 N/A BLA BLA761170 Genentech, Inc. HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB 20000 U/10mL; 600 mg/10mL; 600 mg/10mL 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-01) / 10 mL in 1 VIAL, SINGLE-DOSE
50242-260-86 50242-260 HUMAN PRESCRIPTION DRUG Phesgo pertuzumab, trastuzumab, and hyaluronidase-zzxf INJECTION, SOLUTION SUBCUTANEOUS 20210503 N/A BLA BLA761170 Genentech, Inc. HYALURONIDASE (HUMAN RECOMBINANT); PERTUZUMAB; TRASTUZUMAB 20000 U/10mL; 600 mg/10mL; 600 mg/10mL 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-260-86) / 10 mL in 1 VIAL, SINGLE-DOSE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase